Intellia Therapeutics Stock Price. Everything You Need To Know About The Intellia Therapeutics Stock!
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. The company is headquartered in Cambridge, Massachusetts and currently employs 598 full-time employees. The company went IPO on 2016-05-06. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. The company is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with high unmet need. Its lead in vivo candidate, NTLA-2001, is for the treatment of transthyretin (ATTR) amyloidosis, as well as NTLA-2002 for the treatment of hereditary angioedema (HAE). The company is developing ex vivo applications to address immuno-oncology and autoimmune diseases. Its advanced ex vivo programs include a wholly owned chimeric antigen receptor T (CAR-T) cell candidate, NTLA-6001 targeting CD30 for the treatment of CD30-expressing hematologic cancers, including relapsed or refractory classical Hodgkin’s lymphoma.
Intellia Therapeutics Stock Price. Everything You Need To Know About The Intellia Therapeutics Stock! performance
- Employees 598
- Company HQ Cambridge
- Website https://www.intelliatx.com/
- NTLA Asset Type Common Stock
- NTLA Market Capitalization 2B
- Earnings Per Share -5.42
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Intellia Therapeutics is a cutting-edge biotechnology company that focuses on developing innovative gene-editing treatments for genetic diseases. Investing in Intellia Therapeutics stock can offer an exciting opportunity for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. To invest in Intellia Therapeutics stock, you can follow these simple steps: 1. Choose a Reliable Broker: Select a reputable online broker that allows investors from your country to trade US stocks. 2. Open a Trading Account: Sign up and open a trading account with the chosen broker. Ensure that the account supports international trading. 3. Fund Your Account: Deposit funds into your trading account using one of the available payment methods. 4. Research and Analysis: Conduct thorough research on Intellia Therapeutics, including its financial performance, development pipeline, and market outlook. Leverage the investment insights and recommendations provided by Zorion to make informed decisions. 5. Place Your Order: Using the broker’s trading platform, place an order to buy Intellia Therapeutics stock at the desired price. 6. Monitor and Manage: Keep track of your investment by monitoring the stock’s performance. Consider setting stop-loss orders and take-profit levels to manage your risk effectively. By following these steps and utilizing the investment resources and educational materials provided by Zorion, retail investors from Malaysia, Thailand, Indonesia, and Vietnam can navigate the process of investing in Intellia Therapeutics stock with greater confidence and knowledge. Start your investment journey today and explore the potential growth opportunities offered by this innovative biotechnology company.
